Baolingbao increases investment in wholly-owned subsidiary

On 10 March, 2018, Baolingbao Biology Co., Ltd. (Baolingbao) announced that it would invest another USD11.37 million (RMB72 million) in its wholly-owned subsidiary Shandong Weitiyuan Biotechnology Co., Ltd. (Shandong Weitiyuan) to reinforce the latte...

Sweeteners China News 201803

www.cnchemicals.com